Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label …
…, T Kato, T Hara, K Hamaoka, S Ogawa, M Miura… - The Lancet, 2012 - thelancet.com
Background Evidence indicates that corticosteroid therapy might be beneficial for the primary
treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to …
treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to …
A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population
…, S Matsuda, K Sekine, S Kondo, M Miura… - Journal of the American …, 2016 - Elsevier
Background Several coronary artery Z score models have been developed. However, a Z
score model derived by the lambda-mu-sigma (LMS) method has not been established. …
score model derived by the lambda-mu-sigma (LMS) method has not been established. …
Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events
M Miura, T Kobayashi, T Kaneko, M Ayusawa… - JAMA …, 2018 - jamanetwork.com
Importance Few studies with sufficient statistical power have shown the association of
thezscore of the coronary arterial internal diameter with coronary events (CE) in patients with …
thezscore of the coronary arterial internal diameter with coronary events (CE) in patients with …
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study
…, O Komiyama, H Yamagishi, M Miura - The Lancet Child & …, 2018 - thelancet.com
Background The RAISE study showed that additional prednisolone improved coronary artery
outcomes in patients with Kawasaki disease at high risk of intravenous immunoglobulin (…
outcomes in patients with Kawasaki disease at high risk of intravenous immunoglobulin (…
JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease
…, J Kobayashi, M Ayusawa, H Hamada, M Miura… - Circulation …, 2020 - jstage.jst.go.jp
More than 50 years have passed since Kawasaki disease (KD) was first reported. 1 According
to a nationwide survey, the number of patients with KD who became adults was 136,960 …
to a nationwide survey, the number of patients with KD who became adults was 136,960 …
Revision of diagnostic guidelines for Kawasaki disease .
…, H Matsuura, T Matsubara, M Miura… - Pediatrics …, 2020 - search.ebscohost.com
The article discusses the sixth revised diagnostic guidelines for Kawasaki disease (KD)
among children in Japan. The revisions from the fifth guidelines include fever duration to five …
among children in Japan. The revisions from the fifth guidelines include fever duration to five …
JCS 2018 guideline on diagnosis of chronic coronary heart diseases
…, A Nohara, A Hirayama, N Funabashi, M Miura… - Circulation …, 2021 - jstage.jst.go.jp
Objectives”, explains how to select and use various test methods for evaluating disease
states, the prognosis, and the effects of treatment. References to the literature published since …
states, the prognosis, and the effects of treatment. References to the literature published since …
[HTML][HTML] Patient-specific human induced pluripotent stem cell model assessed with electrical pacing validates S107 as a potential therapeutic agent for …
…, S Ohno, H Itoh, A Takeuchi, S Matsuoka, M Miura… - PLoS …, 2016 - journals.plos.org
Introduction Human induced pluripotent stem cells (hiPSCs) offer a unique opportunity for
disease modeling. However, it is not invariably successful to recapitulate the disease …
disease modeling. However, it is not invariably successful to recapitulate the disease …
Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease
…, T Saji, T Sonobe, S Ogawa, M Miura… - The Pediatric …, 2009 - journals.lww.com
Background: We reported previously that intravenous immunoglobulin (IVIG) plus prednisolone
for initial therapy for Kawasaki disease (KD) prevented coronary artery abnormalities (…
for initial therapy for Kawasaki disease (KD) prevented coronary artery abnormalities (…
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis
K Tanaka, H Shimada, M Miura, Y Fujii… - World journal of …, 2004 - Springer
We determined the relative value of the metastatic colorectal cancer doubling time as a
predictor of recurrence and survival after hepatectomy in comparison with other established …
predictor of recurrence and survival after hepatectomy in comparison with other established …